Yu Hu

61PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Oct 06, 2026
Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma.

|Jul 25, 2026
High IL-10 levels during CRS are negatively associated with NK-cell recovery after CAR-T cell therapy.

|Jul 24, 2026
BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopenia.

|Nov 14, 2025
Integrin αvβ8-mediated TGF-β1 activation regulates the sustained response in immune thrombocytopenia after TPO-RA withdrawal.

Heng Mei, Min Xu, Jinhui Shu

|Jun 30, 2025
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells.

Moran Wang, Ruiqi Zhu, Donald Small

|Jun 30, 2025
Innovative rapid screening for complex BCR-ABL1 kinase domain mutations in TKI-treated leukaemia patients.

Yanping Lan, Jun Deng, Pujing He

Pageof 11

Frequent Collaborators

17 joint publications

Heng Mei

4 joint publications

Jianda Hu

4 joint publications

Qiubai Li

3 joint publications

Fengjuan Fan